Skip to main content
Equibles

IVA · Inventiva S.A.

Track IVA — free

Use IVA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IVA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.35 -0.11 (-3.18%)
Rebalance outlook locked
Market Cap
$796.06M
Shares
236.22M
Volume · Oct 6 2.2M Avg daily vol (3M) 1.43M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.46 Open$3.53 Day$3.29–3.54 52W close$3.26–7.15 Avg vol 30d2.0M Short int4.9M · 2.1% float · 3.6d Short vol45% Last earningsSep 28, 2026 DataJul 2020–Oct 2026

Up next

Next earnings call
Jun 30, 2027 Est · unconfirmed · in 38 wks
Q4 2025 earnings call transcript
call held Mar 31, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$57,158
Trailing 12 months
Net income (TTM)
−$338.62M
Trailing 12 months
Revenue growth YoY
-51.3%
Year over year
Operating margin
-302,981.6%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+102.0%
Year over year · more shares
Price change (1Y)
-44.6%
Trailing year
Short interest
2.1%
Latest settlement · 3.6 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15 · calm Equity put/call 0.57
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −31%
below
Price vs 50-day avg −19%
below
RSI (14) 39
neutral
MACD trend Positive
52-week position 5%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −26%
trailing
6-month return −40%
trailing
YTD return −26%
this year
Relative strength −51%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Accumulating
+35% holders QoQ · +31 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.05% of float · ▲ +31.7% MoM · 3.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
88 holders — near 3-yr high, broad support
Squeeze score 53
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 77%
annualized · 1-yr
Max drawdown −54%
past year
ATR 8.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−31% Bearish
Price vs 50-day avg
−19% Bearish
RSI (14)
39 Neutral
MACD trend
Positive Bullish
52-week position
5% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $4 › 200d $5 — 200d above 50d
Institutional flow Accumulating
+35% holders QoQ · +31 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.05% of float · ▲ +31.7% MoM · 3.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
88 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $3 Now $3 · 5% Range high $7
vs 200-day avg -31% vs 50-day avg -19%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IVA
Inventiva S.A.
this stock
$796.06M -25.6% — — 2.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $133.37B +10.8% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.13B -4.3% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
 $79.40B +535.7% +4.3% — 8.2%
CSLLY
Csl Ltd
 $61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
88
% held
35.8%
Net QoQ
+32.3M sh
Top holder
Caligan Partners LP
Held Float
View
Held by Funds
Fund positions
13
View
Short & Settlement
Short Interest Rising
Shares short
4.9M
Days to cover
3.6d
Change
+1.2M sh
View
Short Volume
Short vol %
45%
As of
Oct 6, 2026
Short Total
View
Fails to Deliver
FTD shares
10.9K
Value
$53.4K
As of
Aug 28, 2026
View
Off-Exchange
Off-exchange %
34.8%
Week of
Aug 31, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 6, 2026
This year
19
View
Earnings & Events
Webcasts
Last webcast
Sep 28, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
IVA +5.2% -25.9% -39.7% -6.2% -25.6%
SPY +2.0% +1.7% +11.3% +2.2% +14.3%
vs SPY +3.2% -27.6% -51.0% -8.4% -39.8%
Key facts CIK 1756594 CUSIP 46124U107 Visit website Investor relations